These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28810525)
1. In vitro anticancer activities of osthole against renal cell carcinoma cells. Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525 [TBL] [Abstract][Full Text] [Related]
2. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566 [TBL] [Abstract][Full Text] [Related]
3. Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways. Ding D; Wei S; Song Y; Li L; Du G; Zhan H; Cao Y Cell Physiol Biochem; 2013; 32(6):1751-60. PubMed ID: 24356539 [TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of osthole on ovarian cancer cells in vitro. Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206 [TBL] [Abstract][Full Text] [Related]
5. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition. Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097 [TBL] [Abstract][Full Text] [Related]
6. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells. Lin ZK; Liu J; Jiang GQ; Tan G; Gong P; Luo HF; Li HM; Du J; Ning Z; Xin Y; Wang ZY Oncol Rep; 2017 Mar; 37(3):1611-1618. PubMed ID: 28184928 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells. Zhao Y; Tang H; Zeng X; Ye D; Liu J Biomed Pharmacother; 2018 Feb; 98():36-44. PubMed ID: 29241073 [TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition. Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway. Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024 [TBL] [Abstract][Full Text] [Related]
10. Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Kao SJ; Su JL; Chen CK; Yu MC; Bai KJ; Chang JH; Bien MY; Yang SF; Chien MH Toxicol Appl Pharmacol; 2012 May; 261(1):105-15. PubMed ID: 22503731 [TBL] [Abstract][Full Text] [Related]
11. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition. Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway. Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793 [TBL] [Abstract][Full Text] [Related]
13. Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM/NF‑κB signaling. Che Y; Li J; Li Z; Li J; Wang S; Yan Y; Zou K; Zou L Oncol Rep; 2018 Aug; 40(2):737-747. PubMed ID: 29989651 [TBL] [Abstract][Full Text] [Related]
14. Osthole induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Chao X; Zhou X; Zheng G; Dong C; Zhang W; Song X; Jin T Pharm Biol; 2014 May; 52(5):544-50. PubMed ID: 24236568 [TBL] [Abstract][Full Text] [Related]
15. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling. Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression. Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475 [TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645 [TBL] [Abstract][Full Text] [Related]
18. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro. Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470 [TBL] [Abstract][Full Text] [Related]
19. Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Xu XM; Zhang Y; Qu D; Feng XW; Chen Y; Zhao L Mol Med Rep; 2012 Nov; 6(5):1018-22. PubMed ID: 22923177 [TBL] [Abstract][Full Text] [Related]
20. Effects of osthole on migration and invasion in breast cancer cells. Yang D; Gu T; Wang T; Tang Q; Ma C Biosci Biotechnol Biochem; 2010; 74(7):1430-4. PubMed ID: 20622464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]